A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study - Ellenbogen,K.A.; Dias,V.C.; Plumb,V.J.; Heywood,J.T.; Mirvis,D.M. (J Am Coll Cardiol, 1991)